PT  - JOURNAL ARTICLE
AU  - Khalil, Marianne
AU  - Hollander, Philippine
AU  - Raucher-Chéné, Delphine
AU  - Lepage, Martin
AU  - Lavigne, Katie M.
TI  - Structural Brain Correlates of Cognitive Function in Schizophrenia: A Meta-Analysis
AID  - 10.1101/2021.04.16.21255551
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.16.21255551
4099  - http://medrxiv.org/content/early/2021/04/20/2021.04.16.21255551.short
4100  - http://medrxiv.org/content/early/2021/04/20/2021.04.16.21255551.full
AB  - Schizophrenia is characterized by cognitive impairments and widespread structural brain alterations (e.g., decreased volume, thickness, surface area). Brain structure-cognition associations have been extensively studied in schizophrenia, typically involving individual cognitive domains or brain regions of interest. Findings in overlapping and diffuse brain regions may point to structural alterations in large-scale brain networks. We performed a systematic review and meta-analysis examining whether brain structure-cognition associations can be explained in terms of biologically meaningful brain networks. Of 7,621 screened articles, 88 were included in a series of meta-analyses assessing publication bias, heterogeneity, and study quality. Significant associations were found between overall brain structure and eight cognitive domains (speed of processing, attention/vigilance, working/verbal/visual memory, executive function, social cognition, and verbal fluency). Brain structure within functionally defined networks (default, dorsal/ventral attention, frontoparietal, limbic, somatosensory, visual) and external structures (amygdala, hippocampus and cerebellum) typically showed associations with conceptually related cognitive domains, with higher-level domains (e.g., executive function, social cognition) associated with more networks. These findings suggest brain structure- cognition associations in schizophrenia may follow network architecture.Competing Interest StatementAuthor ML reports grants from Otsuka Lundbeck Alliance, diaMentis, personal fees from Otsuka Canada, personal fees from Lundbeck Canada, grants and personal fees from Janssen, and personal fees from MedAvante-Prophase, outside the submitted work. Authors MK, PH, DRC, and KML declare no conflict of interests.Funding StatementThis study was supported by grants from the Canadian Institutes of Health Research and the Otsuka/Lundbeck Alliance. Salary awards include postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR) for author KML and James McGill Professorship from McGill University and Research Chair from the FRQS for author ML. The funding sources had no role in the study design, analysis, or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A meta-analysisAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll available data is in the supplementary material submitted